When activated by communications between TAMs and cancer cells, the classical complement pathway is a crucial inflammatory mechanism that promotes the occurrence and development of cancers, increasing cancer cell proliferation and altering the immune profile of tumor-infiltrating leukocytes suppressing CD8+ TIL function (58, 59). This evidence concerns the gene CD8A and neoplasm.